Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 7, 2015 - Issue
Submit an article Journal homepage
142
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan

Ataru Igarashi1 Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
,
Manabu Akazawa2 Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan
,
Tatsunori Murata3 CRECON Medical Assessment Inc., Tokyo, Japan
,
Toshihiko Taguchi4 Department of Orthopaedic Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
,
Alesia Sadosky5 Pfizer Inc., New York, NY, USACorrespondence[email protected]
,
Nozomi Ebata6 Pfizer Japan, Inc., Tokyo, Japan
,
Richard Willke5 Pfizer Inc., New York, NY, USA
,
Koichi Fujii6 Pfizer Japan, Inc., Tokyo, Japan
,
Jim Doherty5 Pfizer Inc., New York, NY, USA
&
Makoto Kobayashi3 CRECON Medical Assessment Inc., Tokyo, Japan
 show all
Pages 505-520 | Published online: 07 Oct 2015

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

William Montgomery, Masayo Sato, Yasuo Nagasaka & Jeffrey Vietri. (2017) The economic and humanistic costs of chronic lower back pain in Japan. ClinicoEconomics and Outcomes Research 9, pages 361-371.
Read now

Articles from other publishers (6)

Ichiro Yoshii, Naoya Sawada & Tatsumi Chijiwa. (2022) Associations between clinical metrics of joint deformity, disease duration, disease activity, functional capacity, quality of life, pain, and fatigue in patients with rheumatoid arthritis. Clinical Rheumatology 42:4, pages 1027-1038.
Crossref
Takuya Yamanaka, Katsushi Takeshita, Takao Mochizuki, Hirokazu Inoue & Toru Akiyama. (2023) Clinical Outcomes of Mirogabalin Treatment for Neuropathic Pain Due to Spinal Diseases in Patients Intolerant to Continuous Administration of Pregabalin. Spine Surgery and Related Research 7:2, pages 136-141.
Crossref
Ichiro Yoshii, Naoya Sawada & Tatsumi Chijiwa. (2022) Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis. Rheumatology International 42:11, pages 1947-1954.
Crossref
Tomoko Tetsunaga, Tomonori Tetsunaga, Keiichiro Nishida, Haruo Misawa, Tomoyuki Takigawa, Kentaro Yamane, Hironori Tsuji, Yoshitaka Takei & Toshifumi Ozaki. (2020) Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study. Journal of Orthopaedic Surgery and Research 15:1.
Crossref
Insa Backhaus, Alice Mannocci & Giuseppe La Torre. (2019) A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment. Current Pharmaceutical Biotechnology 20:11, pages 910-919.
Crossref
Manzumeh-Shamsi Meymandi, Gholamreza Sepehri, Mona Abdolsamadi, Mohammad Shaabani, Gioia Heravi, Omid Yazdanpanah & Mohammadmehdi-Moeini Aghtaei. (2017) The effects of co-administration of pregabalin and vitamin E on neuropathic pain induced by partial sciatic nerve ligation in male rats. Inflammopharmacology 25:2, pages 237-246.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.